Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice is a research paper published in EBioMedicine (2024). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: R01 AI160706
NIAID NIH HHS
Grant: 75N93021C00014
NIAID NIH HHS
Grant: G20 AI174733
NIAID NIH HHS
Grant: R21 AI176069
NIAID NIH HHS
Grant: 75N93019C00051
NIAID NIH HHS
Grant: R01 AI145870
NIDDK NIH HHS
Grant: R01 DK130425
National Institutes of Health
Grant: 5R01AI160706-04
Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy
National Institutes of Health
Grant: 1R01DK130425-01
Experimental and natural SARS-CoV-2 infection of the human pancreas
National Institutes of Health
Grant: 5R21AI176069-02
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
National Institutes of Health
Grant: 1G20AI174733-01
Strengthening the ISMMS research and response capabilities for pathogens of pandemic potential
National Institutes of Health
Grant: 3R01AI145870-02S1
Evaluation of the FcgR mechanisms in the antibody-dependent enhancement of SARS-CoV-2 infection
FWCI
5.21
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords